Immunovia AB (publ)

DB:1YR Stock Report

Market Cap: €10.0m

Immunovia Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1YR?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders21,083,9866.89%
Institutions46,470,43315.2%
General Public238,528,66177.9%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 575.9%.

Top Shareholders

Top 25 shareholders own 22.38% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
11%
Avanza Fonder AB
33,786,585€1.1m11.4%0.01%
1.96%
Vincent Saldell
6,005,000€196.7k0%no data
0.98%
Nordnet AB (publ), Asset Management Arm
2,989,038€97.9k0%0.01%
0.83%
Handelsbanken Asset Management
2,543,813€83.3k0%no data
0.66%
Morgan Stanley, Investment Banking and Brokerage Investments
2,023,450€66.3k0%no data
0.62%
Carl Arne Borrebaeck
1,909,900€62.6k0%no data
0.6%
Andreas Kiviharju
1,830,000€59.9k0%no data
0.59%
Jeff Borcherding
1,820,588€59.6k0%no data
0.55%
Jens Jensen
1,692,555€55.4k0%no data
0.55%
Jens Lensen
1,692,555€55.4k0%no data
0.52%
Försäkringsbolaget Skandia, Asset Management Arm
1,583,668€51.9k0%0.28%
0.5%
Simon Borsos
1,520,000€49.8k0%no data
0.49%
Sten Jonsson
1,500,834€49.2k0%no data
0.48%
Vator Securities AB, Asset Management Arm
1,470,588€48.2k0%100.0%
0.43%
Ghanem Chouba
1,303,968€42.7k0%no data
0.42%
Futur Pension Försäkringsaktiebolag, Asset Management Arm
1,277,265€41.8k0%0.01%
0.28%
Per Ohlin
848,950€27.8k0%no data
0.28%
Sara Andersson Ek
848,907€27.8k0%no data
0.16%
Skandinaviska Enskilda Banken AB, Private Banking, Investment Banking, and Insurance Arm
495,038€16.2k0%no data
0.15%
SEB Investment Management AB
473,678€15.5k0%no data
0.15%
Sten Johnsson
468,500€15.3k0%no data
0.065%
Banor Capital Ltd.
200,000€6.6k0%no data
0.051%
FCG Fonder AB
156,517€5.1k0%no data
0.015%
Storebrand Fonder AB,
46,499€1.5k0%no data
0.0039%
Skandia Fonder AB
11,801€387.00%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/19 15:17
End of Day Share Price 2025/05/16 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Immunovia AB (publ) is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Herman KuntscherCarlsquare AB
Lars HevrengDanske Bank
Juan Pedro Rodríguez SerrateEdison Investment Research